MRI Fusion TRUS-Biopsy
PRE-PROCEDURAL DX: Elevated PSA
POST-PROCEDURAL DX: Same
INDICATION FOR PROCEDURE:
|MRI EXAM|
ANESTHESIA: Local 10 cc 2% lidocaine
PSA: |PSA|
TRUS VOLUME:
PSAD:
BIOPSY OPERATOR: Dr. William Hughes
MRI FUSION OPERATOR:
STAFF:
EBL: Minimal
SPECIMEN: __ Core Prostate Bx
ULTRASOUND FINDINGS:
__ dilations of SV
__ hypoechoic leisons
__ calcificatoins
__ well circumscribed capsule
__ intravesical portion of prostate
DRE: __Palpable Nodules
PROCEDURE IN DETAIL:
Risk, Benefits, and alternatives explained to patient. All questions answered to
patients satisfaction and consented appropriately. Patient states that he has
not been on ASA or any blood thinners for 1 week and has completed the
prescribed bowel prep and antibiotic.
The precedure was begun by gently placing an adequately lubriacated transrectal
ultrasound probe inserted into rectum to the level of the prostate. MRI fusion
software was appropriately calibrated. 10cc of 2% lidocaine was injected in a
prostatic block fashion. The prostate dimensions were measured and size was
automatically calculated.
Core biopies were then taken initially with two cores of each region of
interest with PIRADS 3 or greater using MRI-fusion targeting. Following this,
core biopsies were taken in a sextant fashion. The patient tolerated well
without complication.
CONDITION: Stable
DISPOSITION:
The patient was instructed to follow up in the 2 weeks for results. Patient
instructed to follow up in ER for temp > 101F, intractable bleeding, or urinary
retention. Patient told to expect hematuria and/or blood per rectum for 1 week
and hematospermia for up to 1 month.
Staff Level: I: Staff physically present/directly involved in procedure
Was Procedural Time Out Verification completed prior to procedure?
Yes (PROCEDURAL TIME OUT VERIFICATION TEMPLATE MUST BE COMPLETED!!)